Is Icecure Medical Stock a Good Investment?
Icecure Medical Investment Advice | ICCM |
- Examine Icecure Medical's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Icecure Medical's leadership team and their track record. Good management can help Icecure Medical navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Icecure Medical's business and its evolving consumer preferences.
- Compare Icecure Medical's performance and market position to its competitors. Analyze how Icecure Medical is positioned in terms of product offerings, innovation, and market share.
- Check if Icecure Medical pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Icecure Medical's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Icecure Medical stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Icecure Medical is a good investment.
Sell | Buy |
Strong Hold
Market Performance | Modest | Details | |
Volatility | Very risky | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Icecure Medical Stock
Researching Icecure Medical's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 49.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.28. Icecure Medical had not issued any dividends in recent years. The entity had 1:8 split on the 9th of August 2021.
To determine if Icecure Medical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Icecure Medical's research are outlined below:
| Icecure Medical may become a speculative penny stock | |
| Icecure Medical had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 3.23 M. Net Loss for the year was (14.65 M) with profit before overhead, payroll, taxes, and interest of 1.6 M. | |
| Icecure Medical currently holds about 17.73 M in cash with (12.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.48. | |
| Icecure Medical has a poor financial position based on the latest SEC disclosures | |
| Roughly 49.0% of the company shares are held by company insiders | |
| Latest headline from finance.yahoo.com: IceCure Receives Notice of Allowance in China for Novel Cryogenic Pump for Next-Generation Cryoablation Technology |
Icecure Medical Quarterly Liabilities And Stockholders Equity |
|
Icecure Medical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Icecure Medical. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Icecure Medical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 3rd of April 2024 Upcoming Quarterly Report | View | |
| 27th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 3rd of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Icecure Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Icecure Medical's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-08-20 | 2024-06-30 | -0.07 | -0.06 | 0.01 | 14 | ||
2023-08-14 | 2023-06-30 | -0.09 | -0.08 | 0.01 | 11 | ||
2023-05-22 | 2023-03-31 | -0.09 | -0.08 | 0.01 | 11 | ||
2023-03-29 | 2022-12-31 | -0.1 | -0.11 | -0.01 | 10 | ||
2024-02-20 | 2023-12-31 | -0.0767 | -0.06 | 0.0167 | 21 |
Know Icecure Medical's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Icecure Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Icecure Medical backward and forwards among themselves. Icecure Medical's institutional investor refers to the entity that pools money to purchase Icecure Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Foundations Investment Advisors, Llc | 2024-12-31 | 0.0 | Two Sigma Investments Llc | 2024-12-31 | 0.0 | Virtu Financial Llc | 2024-12-31 | 0.0 | Hrt Financial Llc | 2024-12-31 | 0.0 | Xtx Topco Ltd | 2024-12-31 | 58.9 K | Two Sigma Securities, Llc | 2024-12-31 | 17 K | Renaissance Technologies Corp | 2024-12-31 | 10.9 K | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 6.1 K | Jpmorgan Chase & Co | 2024-12-31 | 6 K | Efficient Wealth Management Llc | 2024-12-31 | 2.5 K | Bank Of America Corp | 2024-12-31 | 862 |
Icecure Medical's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 70.71 M.Market Cap |
|
Icecure Medical's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.80) | (0.84) | |
| Return On Capital Employed | (1.12) | (1.17) | |
| Return On Assets | (0.80) | (0.84) | |
| Return On Equity | (1.39) | (1.32) |
Determining Icecure Medical's profitability involves analyzing its financial statements and using various financial metrics to determine if Icecure Medical is a good buy. For example, gross profit margin measures Icecure Medical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Icecure Medical's profitability and make more informed investment decisions.
Evaluate Icecure Medical's management efficiency
Icecure Medical has return on total asset (ROA) of (0.5255) % which means that it has lost $0.5255 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1135) %, meaning that it created substantial loss on money invested by shareholders. Icecure Medical's management efficiency ratios could be used to measure how well Icecure Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of the 22nd of March 2025, Return On Tangible Assets is likely to drop to -0.84. In addition to that, Return On Capital Employed is likely to drop to -1.17. At this time, Icecure Medical's Non Current Assets Total are very stable compared to the past year. As of the 22nd of March 2025, Non Currrent Assets Other is likely to grow to about 67.8 K, while Total Current Assets are likely to drop about 11.8 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.31 | 0.29 | |
| Tangible Book Value Per Share | 0.31 | 0.29 | |
| Enterprise Value Over EBITDA | (2.30) | (2.41) | |
| Price Book Value Ratio | 3.61 | 3.79 | |
| Enterprise Value Multiple | (2.30) | (2.41) | |
| Price Fair Value | 3.61 | 3.79 | |
| Enterprise Value | 35 M | 60 M |
Icecure Medical showcases strong leadership that adapts to market changes and drives innovation. Our analysis explores how this adaptability affects the stock's investment appeal.
Beta 2.421 |
Basic technical analysis of Icecure Stock
As of the 22nd of March, Icecure Medical retains the Downside Deviation of 3.6, market risk adjusted performance of 1.36, and Risk Adjusted Performance of 0.2065. Icecure Medical technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Icecure Medical downside variance, kurtosis, as well as the relationship between the treynor ratio and standard deviation to decide if Icecure Medical is priced fairly, providing market reflects its last-minute price of 1.25 per share. Given that Icecure Medical is a hitting penny stock territory we urge to closely look at its total risk alpha.Icecure Medical's Outstanding Corporate Bonds
Icecure Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Icecure Medical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Icecure bonds can be classified according to their maturity, which is the date when Icecure Medical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Understand Icecure Medical's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Icecure Medical's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.2065 | |||
| Market Risk Adjusted Performance | 1.36 | |||
| Mean Deviation | 2.91 | |||
| Semi Deviation | 2.54 | |||
| Downside Deviation | 3.6 | |||
| Coefficient Of Variation | 446.55 | |||
| Standard Deviation | 4.23 | |||
| Variance | 17.89 | |||
| Information Ratio | 0.2387 | |||
| Jensen Alpha | 0.9875 | |||
| Total Risk Alpha | 1.28 | |||
| Sortino Ratio | 0.2807 | |||
| Treynor Ratio | 1.35 | |||
| Maximum Drawdown | 23.75 | |||
| Value At Risk | (4.44) | |||
| Potential Upside | 11.82 | |||
| Downside Variance | 12.94 | |||
| Semi Variance | 6.44 | |||
| Expected Short fall | (3.82) | |||
| Skewness | 0.9287 | |||
| Kurtosis | 2.14 |
| Risk Adjusted Performance | 0.2065 | |||
| Market Risk Adjusted Performance | 1.36 | |||
| Mean Deviation | 2.91 | |||
| Semi Deviation | 2.54 | |||
| Downside Deviation | 3.6 | |||
| Coefficient Of Variation | 446.55 | |||
| Standard Deviation | 4.23 | |||
| Variance | 17.89 | |||
| Information Ratio | 0.2387 | |||
| Jensen Alpha | 0.9875 | |||
| Total Risk Alpha | 1.28 | |||
| Sortino Ratio | 0.2807 | |||
| Treynor Ratio | 1.35 | |||
| Maximum Drawdown | 23.75 | |||
| Value At Risk | (4.44) | |||
| Potential Upside | 11.82 | |||
| Downside Variance | 12.94 | |||
| Semi Variance | 6.44 | |||
| Expected Short fall | (3.82) | |||
| Skewness | 0.9287 | |||
| Kurtosis | 2.14 |
Consider Icecure Medical's intraday indicators
Icecure Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Icecure Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Icecure Medical time-series forecasting models is one of many Icecure Medical's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Icecure Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Icecure Stock media impact
Far too much social signal, news, headlines, and media speculation about Icecure Medical that are available to investors today. That information is available publicly through Icecure media outlets and privately through word of mouth or via Icecure internal channels. However, regardless of the origin, that massive amount of Icecure data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Icecure Medical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Icecure Medical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Icecure Medical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Icecure Medical alpha.
Icecure Medical Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Icecure Medical can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Icecure Medical Corporate Management
| Naum Muchnik | Dev Research | Profile | |
| Eyal Shamir | CEO Director | Profile | |
| Galit Malik | Vice Service | Profile | |
| Shay Levav | VP Applications | Profile | |
| Ronen CPA | CFO COO | Profile | |
| Merav Dotan | Vice Resources | Profile | |
| Tlalit TelTzure | Vice Marketing | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Icecure Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Icecure Stock, please use our How to Invest in Icecure Medical guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Icecure Medical. If investors know Icecure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Icecure Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.28) | Revenue Per Share | Quarterly Revenue Growth 1.024 | Return On Assets | Return On Equity |
The market value of Icecure Medical is measured differently than its book value, which is the value of Icecure that is recorded on the company's balance sheet. Investors also form their own opinion of Icecure Medical's value that differs from its market value or its book value, called intrinsic value, which is Icecure Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Icecure Medical's market value can be influenced by many factors that don't directly affect Icecure Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Icecure Medical's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Icecure Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Icecure Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.